Department of Surgery II, School of Medicine, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Department of Diagnostic Radiology, Keio University School of Medicine, 35, Shinanomachi, Shinjyuku-ku, Tokyo, 160-8582, Japan.
Ann Nucl Med. 2022 Oct;36(10):853-864. doi: 10.1007/s12149-022-01767-z. Epub 2022 Jul 11.
The Oncotype DX (ODX) estimates the 10-year risk of metastasis or recurrence of breast cancer and indicates whether chemotherapy is likely to be effective; however, the high cost of this test may limit its use for patients. The aim of this study was to evaluate the potential of preoperative imaging using mammography (MMG), ultrasonography (US), and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), and positron emission tomography/computed tomography (PET/CT) metabolic parameters in predicting the ODX recurrence score (ODXRS), which prognosticates estrogen receptor-positive (ER +)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer.
This retrospective study was conducted on 51 patients with ER+/ HER2- early-stage breast cancer with preoperative images available. Surgical specimens were sent for ODX assay and the ODXRS was categorized as low (<18) or intermediate/high (≥18). MMG/US findings were classified according to BI-RADS categories. For MRI analysis, tumor growth orientation was evaluated in addition to morphological assessment in BI-RADS. For PET/CT analysis, standardized uptake value (SUV) of the tumor were measured. Patient, tumor, and image characteristics were compared between the two groups, and predictors of the low ODXRS group were determined by logistic regression analysis. Two-sided P values less than 0.05 were considered statistically significant.
Thirty-two (63%) and 19 (37%) patients were categorized as low and intermediate/high ODXRS, respectively. On univariate analysis, nuclear grade, tumor margin, and tumor growth orientation on MRI, and SUV on PET/CT were significantly associated with a low ODXRS. Multivariate analysis revealed that tumor growth orientation perpendicular to the Cooper's ligament on MRI (P = 0.031) and a low SUV on PET/CT (P = 0.016) were independent prognostic factors for a low ODXRS. As a predictor of low ODXRS, the receiver operating characteristic (ROC) analysis of the SUV showed that using 3.0 as the optimal cut-off value has a sensitivity and specificity of 94.4% and 73.0%, respectively, with an area under the curve (AUC) of 0.923.
The combination of perpendicular tumor growth orientation to Cooper's ligaments on MRI and a low SUV on PET/CT may predict a low ODXRS.
Oncotype DX(ODX)评估乳腺癌转移或复发的 10 年风险,并表明化疗是否可能有效;然而,该检测的高成本可能限制其在患者中的使用。本研究的目的是评估术前乳腺 X 线摄影(MMG)、超声(US)、动态对比增强磁共振成像(DCE-MRI)和正电子发射断层扫描/计算机断层扫描(PET/CT)代谢参数在预测预测雌激素受体阳性(ER+/HER2-)乳腺癌的 ODX 复发评分(ODXRS)中的潜力。
这项回顾性研究纳入了 51 例有术前图像的 ER+/HER2-早期乳腺癌患者。手术标本进行 ODX 检测,ODXRS 分为低(<18)或中/高(≥18)。根据 BI-RADS 分类对 MMG/US 结果进行分类。对于 MRI 分析,除了 BI-RADS 的形态评估外,还评估肿瘤的生长方向。对于 PET/CT 分析,测量肿瘤的标准化摄取值(SUV)。比较两组患者、肿瘤和图像特征,通过逻辑回归分析确定低 ODXRS 组的预测因素。双侧 P 值<0.05 被认为具有统计学意义。
32 例(63%)和 19 例(37%)患者的 ODXRS 分别为低和中/高。单因素分析显示,核分级、肿瘤边界、MRI 上肿瘤的生长方向和 PET/CT 上的 SUV 与低 ODXRS 显著相关。多因素分析显示,MRI 上与 Cooper 韧带垂直的肿瘤生长方向(P=0.031)和 PET/CT 上的低 SUV(P=0.016)是低 ODXRS 的独立预后因素。作为低 ODXRS 的预测因子,SUV 的受试者工作特征(ROC)分析显示,使用 3.0 作为最佳截断值,灵敏度和特异性分别为 94.4%和 73.0%,曲线下面积(AUC)为 0.923。
MRI 上肿瘤与 Cooper 韧带垂直的生长方向和 PET/CT 上低 SUV 的结合可能预测低 ODXRS。